SlideShare a Scribd company logo
Syndromes of Severe Insulin
Resistance
1
I. Genetic Syndromes of Severe Insulin Resistance
 the most prevalent endocrine derangements in the world
 diabetes mellitus,
 atherosclerosis,
 nonalcoholic fatty liver disease,
 and ovulatory dysfunction
2
It is most commonly found in those with obesity but may also occur in an
unusually severe form in rare patients with monogenic
defects
II. Definition and Prevalence of Severe IR
3
“a state (of a cell, tissue, or organism) in which a greater than normal
amount of insulin is required to elicit a quantitatively normal response”
Insulin resistance may be the underlying
cause of diabetes mellitus type 2 was first
advanced by Prof. Wilhelm Falta and
published in Vienna in 1931
THIS theory confirmed by Sir Harold
Percival Himsworth of the University
College Hospital Medical Centre in
London in 1936.
Genetics
&
Aging
Acquired:
• Central
obesity
• Sedentary
lifestyle
• High fat diet
• Medications
Obesity and less sensitive to insulin
4
5
There are genetic insulin resistance and diet-induced insulin
resistance. Obesity is the most common cause of insulin resistance.
6Mechanisms:
Infiltrating macrophages secret TNFα. TNFα activates JNK and IκB Kinase
(IKK), which phophorylate IRS-1, hence inhibits insulin receptor signaling.
7
8
9
10
Monogenic diabetes
11
Introduction
 Human genome contains more than 3
billion base pairs
 20-25000 genes are believed to code for
proteins
 Single gene defects can lead to diabetes –
independent of environmental influences
 Dominant ,recessive or denovo
 Most are due to mutations in genes
which regulate βcell function
12
13
Mutations in the insulin receptor gene
 The first defects in the INSR were reported in 1988
 more than 100 allelic
14
1.
Rare and severe autosomal recessive
presenting in the first decade of life
Donohue syndrome
Rabson Mendenhall syndrome (RMS)
fasting hypoglycemia,
Postprandial hyperglycemia,
extreme hyperinsulinemia
2. autosomal dominant
 Type A insulin resistance
retarded linear growth, impaired
muscle and dipose tissue
development,
and overgrowth sex ormone-
dependent tissues
such as genitalia and nipples,
and of other tissues including
hair, skin, and viscera
15
16
Why diagnose
monogenic
diabetes
 To elucidate the pathophysiology
 Changes the treatment
 diagnosis has implications for other family members
often correcting their diagnosis, prognosis and treatment
as well as allowing appropriate genetic counselling
17
18
Insulin receptor
Location: 19p13.3-p13.2
Exon count: 22
Two insulin receptor mRNA
transcripts resulting from
alternative splicing of exon
11 in the receptor gene are
expressed in a highly
regulated tissue-specific
fashion
19
Insulin receptor gene
 INSULIN ACTS ON SPECIFIC RECEPTORS
LOCATED ON THE CELL MEMBRANE OF
PRACTICALLY EVERY CELL, BUT THEIR
DENSITY DEPENDS ON THE CELL TYPE:
LIVER AND FAT CELLS ARE VERY RICH.
 THE INSULIN RECEPTOR IS A RECEPTOR
TYROSINE KINASE (RTK) WHICH IS A
HETEROTETRAMERIC GLYCOPROTEIN
CONSISTING OF 2 EXTRACELLULAR Α
2 TRANSMEMBRANE Β SUBUNITS LINKED
TOGETHER BY DISULFIDE BONDS,
ORIENTING ACROSS THE CELL
AS A HETERODIMER
 IT IS ORIENTED ACROSS THE CELL
MEMBRANE AS A HETERODIMER.
 THE Α SUBUNITS CARRY INSULIN
BINDING SITES, WHILE THE Β SUBUNITS
HAVE TYROSINE KINASE ACTIVITY.
INSULIN RECEPTOR; INSR
20
21
Pathology
insulin resistance
leprechaunism,
lipodystrophies,
Rabson-Mendenhall syndrome
type B insulin resistance syndrome
22
23
Rabson–Mendenhall syndrome
24
a rare autosomal recessive disorder
caused by mutations in the insulin receptor gene
INSR, ASN42LYS
INSR, ARG1027TER
INSR, IVS4AS, A-G, -2
INSR, 8-BP DEL, NT2480
To date, 19 different mutations in the INSR gene have
been reported in patients with RMS.
Symptoms
 growth abnormalities of the head, face
and nails,
 acanthosis nigricans
 androgen excess,
 absence of obesity
 massively raised insulin concentrations
25
Inheritance Pattern
affects males and females in equal numbers
Fewer than 50 cases have been reported in the medical
literature
Subjects
The proband (RMS-1) was an 11-year-old Chinese girl, and the only child of
Healthy parents who had no family history of diabetes mellitus or other hereditary
diseases.
29
30
31
32
Standard Therapies
 Treatment
 There is no specific treatment
 The treatment of the disorder is directed toward the specific symptoms
 Affected individuals may receive high doses of insulin or insulin sensitizers,
but in most cases this therapy ultimately proves unsuccessful.
 Treatment may require the coordinated efforts of a team of specialists.
 Pediatricians, surgeons, dental specialists, and other health care
professionals may need to systematically and comprehensively plan an
affected child’s treatment.
 Genetic counseling may be of benefit for affected individuals and their
families. Other treatment is symptomatic and supportive.
33
34
35
Growth charts for the female (A) and male
(B)
siblings. The characteristic growth
retardation of the
RM syndrome is shown. The arrow
indicates when leptin
therapy began.
36
37
Leperchunism Donohue syndrome
leprechaun; (in Irish folklore) a small,
mischievous sprite.
an insulin receptor with greatly
impaired functionality.
intrauterine growth retardation,
fasting hypoglycemia, and death
within the first 1 to 2 years of life
38
Genetics
an autosomal recessive genetic disorder
mutations occurs within
on the short arm chromosome 19 (19p13.2) within
the coding sequence of the INSR gen
production of inactive receptor molecules
Known mutations
a nonsense mutation that resulted in a frame shift
a single missense mutation
and in the milder form; a single codon change that
altered isoleucine to methionine in the receptor
protein
Affected Populations
In reported cases, leprechaunism has occurred twice
as often in females as in males (F2:M1). More
than 50 cases have been reported in the medical
literature.
40
Diagnosis
The diagnosis of leprechaunism may be confirmed by a thorough clinical evaluation, a
detailed patient history, identification of characteristic symptoms and physical findings.
The diagnosis requires measurement of insulin levels, with a blood test, and confirmation
of defective insulin binding on the cells known as fibroblasts.
Prenatal diagnosis is possible through analysis of DNA obtain through a procedure known
as amniocentesis. During amniocentesis, a sample of fluid that surrounds the developing
fetus (amniotic fluid) is removed and studied. DNA obtained from amniotic cells is
analyzed through a test known as polymerase chain reaction (PCR). PCR, a laboratory
technique that many have described as a form of “photocopying,” enables researchers to
enlarge and repeatedly copy sequences of DNA. As a result, they are able to closely
analyze DNA and more easily identify genes and genetic changes (mutations). In
leprechaunism, polymerase chain reaction is used to identify mutations to the insulin
receptor gene.
41
42
43
44
45
46
Syndromes of severe insulin resistance

More Related Content

What's hot

Dyslipidemia lecture
Dyslipidemia lectureDyslipidemia lecture
Dyslipidemia lecture
Hussein Ghannam
 
Hyperlipidemia
HyperlipidemiaHyperlipidemia
Hyperlipidemia
younis zainal
 
Metabolic Syndrome, Diabetes, and Cardiovascular Disease ... Metabolic Synd...
Metabolic Syndrome, Diabetes, and Cardiovascular Disease ... 	 Metabolic Synd...Metabolic Syndrome, Diabetes, and Cardiovascular Disease ... 	 Metabolic Synd...
Metabolic Syndrome, Diabetes, and Cardiovascular Disease ... Metabolic Synd...MedicineAndFamily
 
Metabolic Syndrome and Obesity
Metabolic Syndrome and ObesityMetabolic Syndrome and Obesity
Metabolic Syndrome and Obesitymeducationdotnet
 
Dyslipidemia
DyslipidemiaDyslipidemia
Hypertriglyceridemia in newly diagnosed d.m
Hypertriglyceridemia  in newly diagnosed d.mHypertriglyceridemia  in newly diagnosed d.m
Hypertriglyceridemia in newly diagnosed d.m
Azad Haleem
 
Hypertriglyceridemia
HypertriglyceridemiaHypertriglyceridemia
HypertriglyceridemiaKhloud Abdo
 
Type 1 diabetes mellitus
Type 1 diabetes mellitusType 1 diabetes mellitus
Type 1 diabetes mellitus
priyanka bhardwaj
 
Type 1 Diabetes: Dr Shahjada Selim
Type 1 Diabetes: Dr Shahjada SelimType 1 Diabetes: Dr Shahjada Selim
Type 1 Diabetes: Dr Shahjada Selim
Bangabandhu Sheikh Mujib Medical University
 
Complications of Diabetes Mellitus
Complications of Diabetes MellitusComplications of Diabetes Mellitus
Complications of Diabetes Mellitus
Carmela Domocmat
 
Secondary diabetes
Secondary diabetesSecondary diabetes
Secondary diabetes
Zeeshan Naseer
 
Familial hypercholesterolemia
Familial hypercholesterolemia Familial hypercholesterolemia
Familial hypercholesterolemia
SR,CARDIOLOGY,JIPMER,PUDUCHERRY
 
Management of dyslipidemia
Management of dyslipidemiaManagement of dyslipidemia
Management of dyslipidemia
Amir Mahmoud
 
Diabetes diagnosis
Diabetes diagnosis Diabetes diagnosis
Diabetes diagnosis
ikramdr01
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
Hope Inegbenosun
 
Insulin Resistance A Challenge In Diabetes Management
Insulin Resistance  A Challenge  In Diabetes ManagementInsulin Resistance  A Challenge  In Diabetes Management
Insulin Resistance A Challenge In Diabetes Management
Mrs Aissa Rim
 
Obesity - Pathophysiology, Etiology and management
Obesity - Pathophysiology, Etiology and management Obesity - Pathophysiology, Etiology and management
Obesity - Pathophysiology, Etiology and management
Aneesh Bhandary
 
Homocysteine
HomocysteineHomocysteine
Homocysteine
Tapeshwar Yadav
 

What's hot (20)

Dyslipidemia lecture
Dyslipidemia lectureDyslipidemia lecture
Dyslipidemia lecture
 
Hyperlipidemia
HyperlipidemiaHyperlipidemia
Hyperlipidemia
 
Dyslipidemia
DyslipidemiaDyslipidemia
Dyslipidemia
 
Metabolic Syndrome, Diabetes, and Cardiovascular Disease ... Metabolic Synd...
Metabolic Syndrome, Diabetes, and Cardiovascular Disease ... 	 Metabolic Synd...Metabolic Syndrome, Diabetes, and Cardiovascular Disease ... 	 Metabolic Synd...
Metabolic Syndrome, Diabetes, and Cardiovascular Disease ... Metabolic Synd...
 
Metabolic Syndrome and Obesity
Metabolic Syndrome and ObesityMetabolic Syndrome and Obesity
Metabolic Syndrome and Obesity
 
Dyslipidemia
DyslipidemiaDyslipidemia
Dyslipidemia
 
Hypertriglyceridemia in newly diagnosed d.m
Hypertriglyceridemia  in newly diagnosed d.mHypertriglyceridemia  in newly diagnosed d.m
Hypertriglyceridemia in newly diagnosed d.m
 
Hypertriglyceridemia
HypertriglyceridemiaHypertriglyceridemia
Hypertriglyceridemia
 
Type 1 diabetes mellitus
Type 1 diabetes mellitusType 1 diabetes mellitus
Type 1 diabetes mellitus
 
Type 1 Diabetes: Dr Shahjada Selim
Type 1 Diabetes: Dr Shahjada SelimType 1 Diabetes: Dr Shahjada Selim
Type 1 Diabetes: Dr Shahjada Selim
 
Complications of Diabetes Mellitus
Complications of Diabetes MellitusComplications of Diabetes Mellitus
Complications of Diabetes Mellitus
 
Secondary diabetes
Secondary diabetesSecondary diabetes
Secondary diabetes
 
Familial hypercholesterolemia
Familial hypercholesterolemia Familial hypercholesterolemia
Familial hypercholesterolemia
 
Management of dyslipidemia
Management of dyslipidemiaManagement of dyslipidemia
Management of dyslipidemia
 
Diabetes diagnosis
Diabetes diagnosis Diabetes diagnosis
Diabetes diagnosis
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
Insulin Resistance A Challenge In Diabetes Management
Insulin Resistance  A Challenge  In Diabetes ManagementInsulin Resistance  A Challenge  In Diabetes Management
Insulin Resistance A Challenge In Diabetes Management
 
Obesity - Pathophysiology, Etiology and management
Obesity - Pathophysiology, Etiology and management Obesity - Pathophysiology, Etiology and management
Obesity - Pathophysiology, Etiology and management
 
Hyperlipidemia
HyperlipidemiaHyperlipidemia
Hyperlipidemia
 
Homocysteine
HomocysteineHomocysteine
Homocysteine
 

Similar to Syndromes of severe insulin resistance

Pathogenesis systemic lupus erythematosus by dr bashir ahmed dar associate pr...
Pathogenesis systemic lupus erythematosus by dr bashir ahmed dar associate pr...Pathogenesis systemic lupus erythematosus by dr bashir ahmed dar associate pr...
Pathogenesis systemic lupus erythematosus by dr bashir ahmed dar associate pr...
Prof Dr Bashir Ahmed Dar
 
Revisión: Resistencia a la insulina y el síndrome de ovario poliquístico. Una...
Revisión: Resistencia a la insulina y el síndrome de ovario poliquístico. Una...Revisión: Resistencia a la insulina y el síndrome de ovario poliquístico. Una...
Revisión: Resistencia a la insulina y el síndrome de ovario poliquístico. Una...
Bladimir Viloria
 
Homocystinuria pdf
Homocystinuria pdfHomocystinuria pdf
Homocystinuria pdf
TingYoongTee
 
Genetic presentation
Genetic presentationGenetic presentation
Genetic presentationBintIbri
 
Clinical insights and challenges: A rare case report of Leigh syndrome
Clinical insights and challenges: A rare case report of Leigh syndromeClinical insights and challenges: A rare case report of Leigh syndrome
Clinical insights and challenges: A rare case report of Leigh syndrome
bijnnjournal
 
Ipoglicemia da iperinsulinemia
Ipoglicemia da iperinsulinemiaIpoglicemia da iperinsulinemia
Ipoglicemia da iperinsulinemiaMerqurio
 
Autoimmune Diseases.
Autoimmune Diseases.Autoimmune Diseases.
Autoimmune Diseases.
Jiten Shah
 
Pediatrics 5th year, 15th lecture/part one (Dr. Jamal)
Pediatrics 5th year, 15th lecture/part one (Dr. Jamal)Pediatrics 5th year, 15th lecture/part one (Dr. Jamal)
Pediatrics 5th year, 15th lecture/part one (Dr. Jamal)
College of Medicine, Sulaymaniyah
 
Genetics
GeneticsGenetics
Genetic disorders pdf
Genetic disorders pdfGenetic disorders pdf
Genetic disorders pdf
jrseema
 
Marfan syndrome
Marfan syndromeMarfan syndrome
Marfan syndrome
zakariy al-nuaimi
 
Genetic disorders
Genetic  disordersGenetic  disorders
Genetic disorders
Abdelrahman Mosaad
 
lifestyle disorders:diabetes
lifestyle disorders:diabeteslifestyle disorders:diabetes
lifestyle disorders:diabetesLee-Ann Kara
 
Diabetes mellitus and periodontitis
Diabetes mellitus and periodontitisDiabetes mellitus and periodontitis
Diabetes mellitus and periodontitis
Dr. Shweta Sarate
 
systemic lupus erythematosus
systemic lupus  erythematosussystemic lupus  erythematosus
systemic lupus erythematosus
Kirsha K S
 
15 Genetic Diseases
15 Genetic Diseases15 Genetic Diseases
15 Genetic Diseasesghalan
 
Genetic disease
Genetic diseaseGenetic disease
Genetic disease
SoniaBajaj10
 

Similar to Syndromes of severe insulin resistance (20)

Pathogenesis systemic lupus erythematosus by dr bashir ahmed dar associate pr...
Pathogenesis systemic lupus erythematosus by dr bashir ahmed dar associate pr...Pathogenesis systemic lupus erythematosus by dr bashir ahmed dar associate pr...
Pathogenesis systemic lupus erythematosus by dr bashir ahmed dar associate pr...
 
Revisión: Resistencia a la insulina y el síndrome de ovario poliquístico. Una...
Revisión: Resistencia a la insulina y el síndrome de ovario poliquístico. Una...Revisión: Resistencia a la insulina y el síndrome de ovario poliquístico. Una...
Revisión: Resistencia a la insulina y el síndrome de ovario poliquístico. Una...
 
Homocystinuria pdf
Homocystinuria pdfHomocystinuria pdf
Homocystinuria pdf
 
Genetic presentation
Genetic presentationGenetic presentation
Genetic presentation
 
Clinical insights and challenges: A rare case report of Leigh syndrome
Clinical insights and challenges: A rare case report of Leigh syndromeClinical insights and challenges: A rare case report of Leigh syndrome
Clinical insights and challenges: A rare case report of Leigh syndrome
 
Ipoglicemia da iperinsulinemia
Ipoglicemia da iperinsulinemiaIpoglicemia da iperinsulinemia
Ipoglicemia da iperinsulinemia
 
Autoimmune Diseases.
Autoimmune Diseases.Autoimmune Diseases.
Autoimmune Diseases.
 
Pediatrics 5th year, 15th lecture/part one (Dr. Jamal)
Pediatrics 5th year, 15th lecture/part one (Dr. Jamal)Pediatrics 5th year, 15th lecture/part one (Dr. Jamal)
Pediatrics 5th year, 15th lecture/part one (Dr. Jamal)
 
Genetics
GeneticsGenetics
Genetics
 
Genetic disorders pdf
Genetic disorders pdfGenetic disorders pdf
Genetic disorders pdf
 
Marfan syndrome
Marfan syndromeMarfan syndrome
Marfan syndrome
 
Genetic disorders
Genetic  disordersGenetic  disorders
Genetic disorders
 
Genetic disease
Genetic diseaseGenetic disease
Genetic disease
 
Obesity ppt 2
Obesity ppt 2Obesity ppt 2
Obesity ppt 2
 
lifestyle disorders:diabetes
lifestyle disorders:diabeteslifestyle disorders:diabetes
lifestyle disorders:diabetes
 
Diabetes mellitus and periodontitis
Diabetes mellitus and periodontitisDiabetes mellitus and periodontitis
Diabetes mellitus and periodontitis
 
systemic lupus erythematosus
systemic lupus  erythematosussystemic lupus  erythematosus
systemic lupus erythematosus
 
HES
HESHES
HES
 
15 Genetic Diseases
15 Genetic Diseases15 Genetic Diseases
15 Genetic Diseases
 
Genetic disease
Genetic diseaseGenetic disease
Genetic disease
 

Recently uploaded

Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
Sai Sailesh Kumar Goothy
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
Suraj Goswami
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
AkankshaAshtankar
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
Dr Maria Tamanna
 

Recently uploaded (20)

Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
 

Syndromes of severe insulin resistance

  • 1. Syndromes of Severe Insulin Resistance 1
  • 2. I. Genetic Syndromes of Severe Insulin Resistance  the most prevalent endocrine derangements in the world  diabetes mellitus,  atherosclerosis,  nonalcoholic fatty liver disease,  and ovulatory dysfunction 2 It is most commonly found in those with obesity but may also occur in an unusually severe form in rare patients with monogenic defects
  • 3. II. Definition and Prevalence of Severe IR 3 “a state (of a cell, tissue, or organism) in which a greater than normal amount of insulin is required to elicit a quantitatively normal response” Insulin resistance may be the underlying cause of diabetes mellitus type 2 was first advanced by Prof. Wilhelm Falta and published in Vienna in 1931 THIS theory confirmed by Sir Harold Percival Himsworth of the University College Hospital Medical Centre in London in 1936. Genetics & Aging Acquired: • Central obesity • Sedentary lifestyle • High fat diet • Medications
  • 4. Obesity and less sensitive to insulin 4
  • 5. 5 There are genetic insulin resistance and diet-induced insulin resistance. Obesity is the most common cause of insulin resistance.
  • 6. 6Mechanisms: Infiltrating macrophages secret TNFα. TNFα activates JNK and IκB Kinase (IKK), which phophorylate IRS-1, hence inhibits insulin receptor signaling.
  • 7. 7
  • 8. 8
  • 9. 9
  • 10. 10
  • 12. Introduction  Human genome contains more than 3 billion base pairs  20-25000 genes are believed to code for proteins  Single gene defects can lead to diabetes – independent of environmental influences  Dominant ,recessive or denovo  Most are due to mutations in genes which regulate βcell function 12
  • 13. 13
  • 14. Mutations in the insulin receptor gene  The first defects in the INSR were reported in 1988  more than 100 allelic 14 1. Rare and severe autosomal recessive presenting in the first decade of life Donohue syndrome Rabson Mendenhall syndrome (RMS) fasting hypoglycemia, Postprandial hyperglycemia, extreme hyperinsulinemia 2. autosomal dominant  Type A insulin resistance retarded linear growth, impaired muscle and dipose tissue development, and overgrowth sex ormone- dependent tissues such as genitalia and nipples, and of other tissues including hair, skin, and viscera
  • 15. 15
  • 16. 16
  • 17. Why diagnose monogenic diabetes  To elucidate the pathophysiology  Changes the treatment  diagnosis has implications for other family members often correcting their diagnosis, prognosis and treatment as well as allowing appropriate genetic counselling 17
  • 19. Location: 19p13.3-p13.2 Exon count: 22 Two insulin receptor mRNA transcripts resulting from alternative splicing of exon 11 in the receptor gene are expressed in a highly regulated tissue-specific fashion 19 Insulin receptor gene
  • 20.  INSULIN ACTS ON SPECIFIC RECEPTORS LOCATED ON THE CELL MEMBRANE OF PRACTICALLY EVERY CELL, BUT THEIR DENSITY DEPENDS ON THE CELL TYPE: LIVER AND FAT CELLS ARE VERY RICH.  THE INSULIN RECEPTOR IS A RECEPTOR TYROSINE KINASE (RTK) WHICH IS A HETEROTETRAMERIC GLYCOPROTEIN CONSISTING OF 2 EXTRACELLULAR Α 2 TRANSMEMBRANE Β SUBUNITS LINKED TOGETHER BY DISULFIDE BONDS, ORIENTING ACROSS THE CELL AS A HETERODIMER  IT IS ORIENTED ACROSS THE CELL MEMBRANE AS A HETERODIMER.  THE Α SUBUNITS CARRY INSULIN BINDING SITES, WHILE THE Β SUBUNITS HAVE TYROSINE KINASE ACTIVITY. INSULIN RECEPTOR; INSR 20
  • 22. 22
  • 23. 23
  • 24. Rabson–Mendenhall syndrome 24 a rare autosomal recessive disorder caused by mutations in the insulin receptor gene INSR, ASN42LYS INSR, ARG1027TER INSR, IVS4AS, A-G, -2 INSR, 8-BP DEL, NT2480 To date, 19 different mutations in the INSR gene have been reported in patients with RMS.
  • 25. Symptoms  growth abnormalities of the head, face and nails,  acanthosis nigricans  androgen excess,  absence of obesity  massively raised insulin concentrations 25
  • 26.
  • 27. Inheritance Pattern affects males and females in equal numbers Fewer than 50 cases have been reported in the medical literature
  • 28. Subjects The proband (RMS-1) was an 11-year-old Chinese girl, and the only child of Healthy parents who had no family history of diabetes mellitus or other hereditary diseases.
  • 29. 29
  • 30. 30
  • 31. 31
  • 32. 32
  • 33. Standard Therapies  Treatment  There is no specific treatment  The treatment of the disorder is directed toward the specific symptoms  Affected individuals may receive high doses of insulin or insulin sensitizers, but in most cases this therapy ultimately proves unsuccessful.  Treatment may require the coordinated efforts of a team of specialists.  Pediatricians, surgeons, dental specialists, and other health care professionals may need to systematically and comprehensively plan an affected child’s treatment.  Genetic counseling may be of benefit for affected individuals and their families. Other treatment is symptomatic and supportive. 33
  • 34. 34
  • 35. 35 Growth charts for the female (A) and male (B) siblings. The characteristic growth retardation of the RM syndrome is shown. The arrow indicates when leptin therapy began.
  • 36. 36
  • 37. 37
  • 38. Leperchunism Donohue syndrome leprechaun; (in Irish folklore) a small, mischievous sprite. an insulin receptor with greatly impaired functionality. intrauterine growth retardation, fasting hypoglycemia, and death within the first 1 to 2 years of life 38
  • 39. Genetics an autosomal recessive genetic disorder mutations occurs within on the short arm chromosome 19 (19p13.2) within the coding sequence of the INSR gen production of inactive receptor molecules Known mutations a nonsense mutation that resulted in a frame shift a single missense mutation and in the milder form; a single codon change that altered isoleucine to methionine in the receptor protein Affected Populations In reported cases, leprechaunism has occurred twice as often in females as in males (F2:M1). More than 50 cases have been reported in the medical literature.
  • 40. 40 Diagnosis The diagnosis of leprechaunism may be confirmed by a thorough clinical evaluation, a detailed patient history, identification of characteristic symptoms and physical findings. The diagnosis requires measurement of insulin levels, with a blood test, and confirmation of defective insulin binding on the cells known as fibroblasts. Prenatal diagnosis is possible through analysis of DNA obtain through a procedure known as amniocentesis. During amniocentesis, a sample of fluid that surrounds the developing fetus (amniotic fluid) is removed and studied. DNA obtained from amniotic cells is analyzed through a test known as polymerase chain reaction (PCR). PCR, a laboratory technique that many have described as a form of “photocopying,” enables researchers to enlarge and repeatedly copy sequences of DNA. As a result, they are able to closely analyze DNA and more easily identify genes and genetic changes (mutations). In leprechaunism, polymerase chain reaction is used to identify mutations to the insulin receptor gene.
  • 41. 41
  • 42. 42
  • 43. 43
  • 44. 44
  • 45. 45
  • 46. 46